Stem Cell Therapy for Rheumatoid Arthritis


Rheumatoid arthritis, or RA, affects over 1.5 million people in the United States. RA a type of autoimmune disease that attacks the joints and causes inflammation. This inflammation can be damaging to both the cartilage and the bones of the joint, and this damage can limit the ability of the joint to move or make the joint loose. Patients with rheumatoid arthritis also experience pain, swelling, and joint stiffness. Severe cases of RA can lead to loss of mobility and permanent disability for some people. Other symptoms include dry eyes, impaired vision, sensitivity to light, shortness of breath, inflammation of blood vessels, anemia and changes in the skin near the joints. Rheumatoid arthritis most frequently affects the knees, ankles, feet, elbows, and hands, but it can also affect the systems of the body, like the digestive system and the respiratory system.

For patients with rheumatoid arthritis, Innovations Stem Cell Center deploys SVF stem cells through IV along with injections. Damaged tissue attracts stem cells through growth factor chemical messages, and deployed stem cells find the damaged or diseased tissue and begin repairs.

Patients begin seeing results in the first few weeks of treatment. Some patients may require additional deployment.